Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Savicell logo — THE IMMUNOBIOPSY™ COMPANY – BECAUSE EARLY DETECTION IS LIFE™

Savicell

THE IMMUNOBIOPSY™ COMPANY – BECAUSE EARLY DETECTION IS LIFE™

Founded 2007 Israel Israel 7 employees Biotechnology, Health Care

General Information

Company Name Savicell
Founded Year 2007
Location Israel Israel +1
Employees 7
Industries Biotechnology, Health Care
Social

Get notified when Savicell moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Savicell

Savicell is a biotechnology startup based in Israel established in 2007. The company focuses on early disease detection, particularly cancer, with its innovative Well-Shield™ platform. Savicell's liquid ImmunoBiopsy™ technology aims to identify various diseases and track treatment effectiveness, including immunotherapy, in the underserved cancer liquid biopsy market. The company's approach is based on the understanding that metabolic changes in the immune system impact immune response outcomes, allowing for disease-specific identification based on unique immune metabolic profiles. By measuring these energy changes, Savicell's Liquid ImmunoBiopsy can distinguish between and within various ailments, such as cancers, autoimmune diseases, and infectious diseases. With its groundbreaking technology and strategic focus on early disease detection, Savicell is poised to make a significant impact in the biotechnology and healthcare industries.

Taxonomy: Cancer detection, Liquid biopsy, Early disease detection, Metabolomics, Immunotherapy, Medical diagnostics, Immune system analysis, Infectious disease detection

No funding data available for Savicell yet.

Get notified when Savicell raises funding

Savicell Alternatives & Competitors

Savicell vs
Volition
Volition United States

Revolutionizing early disease diagnosis for a brighter tomorrow

IPO
86 employees
Savicell vs
Orbit Genomics
Orbit Genomics United States

The Future of Precision Healthcare

Unknown
8 employees
Savicell vs
miR Scientific, LLC
miR Scientific, LLC United States

miR Scientific is a healthcare company that is committed to transforming cancer management globally.

14 employees
Biotechnology, Health Care

FAQ About Savicell

THE IMMUNOBIOPSY™ COMPANY – BECAUSE EARLY DETECTION IS LIFE™
Savicell was founded in 2007.
Savicell is headquartered in Israel.
Savicell operates in the following industries: Biotechnology, Health Care.
Savicell has approximately 7 employees.
Top alternatives and competitors to Savicell include Volition, Orbit Genomics, miR Scientific, LLC, Early is Good, JaxBio. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Savicell and Volition are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Savicell and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy